PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Neuroimmunomodulation. Author manuscript; available in PMC 2014 February 22.
Published in final edited form as:
PMCID: PMC3932154
NIHMSID: NIHMS484813

Acute Painful Stress and Inflammatory Mediator Production

Abstract

Pro-inflammatory pathways may be activated under conditions of painful stress, which is hypothesized to worsen the pain experience and place medically-vulnerable populations at risk for increased morbidity.

Objectives

To evaluate the effects of pain and subjective pain-related stress on pro-inflammatory activity.

Methods

A total of 19 healthy control subjects underwent a single standard cold-pressor pain test (CPT) and a no-pain control condition. Indicators of pain and stress were measured and related to inflammatory immune responses (CD811a, IL-1RA, and IL-6) immediately following the painful stimulus, and compared to responses under non-pain conditions. Heart rate and mean arterial pressure were measured as indicators of sympathetic stimulation.

Results

CPT was clearly painful and generated an activation of the sympathetic nervous system. CD811a increased in both conditions, but with no statistically significant greater increase following CPT (p < .06). IL-1RA demonstrated a non-statistically significant increase following CPT (p < .07). The change in IL-6 following CPT differed significantly from the response seen in the control condition (p < .02).

Conclusions

These findings suggest that CP acute pain may affect proinflammatory pathways, possibly through mechanisms related to adrenergic activation.

Keywords: pain, stress, cytokines, cellular adhesion molecules, neuro-hormonal response, neuro-immune

Introduction

The experience of pain is accompanied by a stress response, mediated through humoral and neural pathways [1]. Specifically, nociceptor activation transduces noxious environmental stimuli into electrical signals, transmitted via afferent pain nerves to the dorsal horn of the spinal cord [2]. As neural signals ascend rostrally through brainstem and limbic brain structures (e.g., hypothalamus, locus coeruleus), the neuroendocrine and sympathetic nervous system is activated and plasma and synaptic levels of epinephrine, norepinephrine, and cortisol rise [1].

Evidence exists to suggest that these stress-related hormones interact with immune cells, and result in changes in intracellular signaling pathways and phenotypical expression consistent with inflammatory activity [3,4,5]. For example, intracellular levels of nuclear factor Kappa-B (NFKB), a signal transcription factor critical to multiple inflammatory pathways, are elevated following stressful experiences and exposure to catecholamines [6,7,8,9,10]. Cellular adhesion molecules (CAMs), critical for cell migration to sites of inflammatory activity, are present in higher concentrations in the plasma following various psychological and physiological stressors including public speaking, exercise, and care-giving [3,5,11,12,13,14]. Furthermore, we recently reported a relationship between psychological responses to pain and CAM expression on leukocytes [15]. There is a dearth of investigations evaluating the effects of painful nociceptive stress, as an antecedant condition, on markers of inflammatory activity in human subjects.

In the current study, a standard pain induction technique (cold pressor testing [CPT]) was used to investigate whether experimental induction of sensory and psychological responses to pain is associated with increases in markers of inflammation. To this end, changes in the expression of the integrin cellular adhesion molecule, CD11a on CD8+ immune cells (CD811a), plasma levels of interleukin-1 receptor antagonist (IL-1RA), and plasma levels of the proinflammatory cytokine interleukin-6 (IL-6) were measured immediately following CPT, and inspected with respect to psychological and physiological pain responses.

Materials and Methods

Design

Using a two factor within-subjects experimental design, a sample of 19 healthy control subjects underwent both a CPT pain and a non-pain condition, in random order and separated by at least 48 hours. Measures were collected at baseline (5 minutes prior to immersion = T0); T0+ (approximately)10 min =T1.

Sample

A convenience sample of 19 (9 female) volunteers was recruited from the university community. Inclusion criteria included being in good health and age between 18–30 years. Exclusion criteria included chronic ingestion of any medications including analgesics, adrenergic and antihistamine cold medications, and steroids; the presence of any acute or chronic immune-altering illness, and a history of any chronic pain syndromes or abnormal reactions to pain. A power analysis based on the data of Mills and colleagues [5] describing leukocyte integrin CAM responses to an adrenergic stressor suggested that a sample size of 10 would have 80% power to detect a difference at a .05 two-sided significance level. The study was approved by the Medical Institutional Review Board of the University of California at Los Angeles, and each subject gave informed consent prior to study participation. Subjects were financially compensated for their participation.

Procedures

All study procedures were performed at the Clinical Translational Research Center, University of California, Los Angeles. Study sessions began at 0800 with the application of automated blood pressure cuff, electrocardiogram, pulse oximeter and insertion of a 22-gauge angiocatheter into the subject’s antecubital fossa for blood sampling. There were two data collection time points. At T0, 5 minutes prior to CPT, baseline measures were obtained. At T1, immediately following CPT (approximately T0 + 10 minutes), measurements were again obtained. In the control session, subjects rested comfortably supine in bed, and vital signs were measured, pain instruments were completed, and timed blood samples were drawn corresponding to the data collection time points for the CPT session. Following session completion, subjects were evaluated and discharged.

Pain Induction

For the pain condition, a standardized cold pressor experimental pain induction technique was used. With this widely used experimental pain induction method, a body limb (typically the arm) is immersed in 0–2ºC water, reliably producing an aching pain of clinical quality and intensity. The ice water provides an acute and tonic noxious cold pain stimulus, activating peripheral nociceptors and central pain systems, and is accompanied by a well-described sympathetic nervous system response [16,17]. CPT pain responses are highly reproducible [17,18,19,20,21,22] and analogous in nature to various types of clinical pain [22].

The pain induction procedure as adapted by Eckhardt et al. [23] for the pharmaceutical industry was utilized. Subjects were seated comfortably in front of plastic containers, one filled with warm (37.8°) and one with cold (1.0 +/− 0.5° C) water. A water pump in the container prevented laminar warming around the immersed limb. A blood pressure cuff was applied to the non-dominant arm, and a blindfold was secured over the eyes to reduce distractions. Other than instructions, subjects were not spoken to during testing. The forearm was immersed in the warm water with fingers spread wide apart with instructions not to touch the container, and timing began.

At 1 minute and 45 seconds, the blood pressure cuff was inflated to 20 mm Hg below the diastolic BP to induce ischemia prior to determining the reaction to cold. At exactly 2 minutes, subjects were assisted in removing the forearm from the warm water container and fully immersing it with fingers spread wide into the coldwater container, not touching sides or bottom. Subjects were instructed to say “pain” when the cold sensation became painful (threshold) and then kept the limb immersed until the pain was intolerable, at which point the arm was removed (tolerance). Vital signs were recorded, and pain severity and stress responses were assessed (see Measures) concurrently with blood sampling.

Measures

Pain

Pain severity was measured using the McGill Pain Questionnaire Short Form (MPQSF) [24,25,26]). This instrument, which measures the: sensory, affective and evaluative aspects of pain [27,28], has established validity and reliability, and is widely used in experimental and clinical settings [29,30,31]. Due to the short data-collection window, the brief version of the MPQ (Short Form) [MPQSF] [32] was used. Subjects took approximately 90 sec to complete the instrument at each sampling time point, with possible scores ranging from 0(mild) to 50(severe). The instrument includes a 10 cm pain visual analog scale (VAS) anchored with 0 being no pain and 10 cm “severe pain”, and a five-division categorical rating scale of present pain intensity. In addition to the subjects’ reports of pain, the length of time (sec) to the first complaint of pain (threshold) and the total immersion time (tolerance) following cold water immersion were collected as behavioral indicators of pain.

Stress

Psychological stress experienced during painful stimulation was assessed using a 10 cm visual analogue scale (VAS) with the following end anchors: “I feel no stress” ----“I feel extremely stressed”. Although a broad measure of stress, the VAS has well-established reliability and validity in the assessment of many subjective symptoms (i.e., pain, dyspnea, fatigue) [33,34,35]. In addition, mean arterial blood pressure (MAP) and heart rate (HR) were collected as indicators of stress-related sympathetic nervous system activation [36].

Immune Responses

Blood samples were collected into EDTA tubes at T0 (i.e., baseline, 5 minutes prior to experimental condition) and at T1, following arm removal from the cold bath (T0 + approximately 10 minutes). CAM expression was evaluated in whole blood by flow cytometry, and reported as the absolute number of CD8-positive T lymphocytes expressing the integrin molecule CD11a (CD8+11a+) as previously described [15]. CD11a was chosen for investigation since it is a ubiquitous, critically important molecule in leukocyte migration [37]. Plasma was obtained by centrifugation, and frozen at −80°C until tested by enzyme linked immunosorbent assay (ELISA); all four plasma samples from each subject were tested together in the same assay plate. Plasma concentrations of IL-6, a pro-inflammatory cytokine known to be responsive to stress [38], were determined using the Quantikine high-sensitivity IL-6 ELISA (R&D Systems, Minneapolis, MN), according to the manufacturer’s protocol. Plasma concentrations of IL-1, another pro-inflammatory cytokine, are observed to respond to pain, [39]. IL-1 receptor antagonist (IL-1RA), a soluble molecule released from cells in parallel with IL-1, is easily detectable in the plasma and is often used as a marker of IL-1 activity [40] and was measured in this study as an indicator of IL-1 activity. Plasma concentrations of IL-1RA were determined using the Quantikine ELISA (R&D Systems) according to the manufacturer’s protocol. Intra-assay and inter-assay variation were <5% for IL-6 and <12% for IL1-RA.

Data Analysis

In this two-factor within subjects design, subjects were observed under two experimental conditions (CP and no pain) over time. Change scores were calculated for each condition for the difference between measures taken at baseline, prior to experimental condition, and 5 minutes after the end of the experimental manipulation. Means and standard deviations of these change scores were calculated for descriptive purposes. The standard errors were calculated for display of confidence intervals in the Figure. Data was analyzed using the non-parametric sign rank test to assess significant differences between the change scores for the two conditions in the experiment. SAS 9.2 was used for all analyses.

Figure
Immune variable change scores in response to pain

RESULTS

Demographic Data

The sample had a mean age of 24.3 years, a BMI of 23.4, and a mixed ethnic composition as seen in Table 1.

Table 1
Subject Demographics

Pain

As seen in Table 2, immediately following CP, pain scores on the MPQSF instrument were significantly elevated from baseline, VAS ratings averaged 7.0 cm out 10 cm, supporting that the CP induced pain of moderate to severe scores. Pain threshold averaged 25.98 sec and tolerance 51.29 sec for the sample. No subject reported any post-CPT pain. No pain measure was related to any immune variable change.

Table 2
Cold Pressor Test-related activation of pain and stress

Stress

As seen in Table 2, stress VAS scores increased significantly from baseline following CPT. Supporting the CPT as a sympathetic stimulus, significant increases in HR and MAP were observed post-CPT. Not unexpectedly, pain severity and stress scores were highly correlated (ranges reported: r= .53–.75; p < 002 – .0182). No stress measure was related to any immune variable changes.

Immune Responses

Changes in immune measures in response to CP pain are displayed in Table 3. No statistically significant increases were seen in response to the painful stimulus, which are displayed graphically via change scores in the Figure.

Table 3
Cold Pressor Test-related activation of immune variables

Number of CD11a molecules on CD8+ cells

The mean number of CD8+CD11a+ cells per µL increased significantly in both conditions over time. Though CD811a changed significantly in both conditions, the larger magnitude of change in the experimental condition showed no statistically significant difference between the two groups (see Table 3 and the Figure).

Cytokines

IL-6

IL-6 did not increase significantly in response to CPT. However, the positive change in IL-6 was significantly greater in the CPT condition than in the control condition (see Table 3 and the Figure). There was no relationship between IL-6 and IL-1RA, or integrin expression on CD8+ cells.

IL-1RA

Though the change between the two conditions was not different, the greater change in IL-1 RA in the pain condition did not achieve statistical significance (see Table 3 and the Figure).

Discussion

This study sought to determine if a cold pressor experimental pain stimulus would serve to initiate inflammatory immune signaling pathways. Based upon pre-clinical and experimental studies [4,5,38,41,42], the investigators hypothesized that the neurohumoral responses to pain would result in proinflammatory changes in leukocytes (increased expression of CD11a on CD8+ lymphocytes) and the production of inflammatory molecules (IL-1RA and IL-6).

Providing experimental support for this hypothesis, a number of investigations have demonstrated that many types of stressors are associated with increased integrin CAMs on leukocytes, via adrenergic interactions [3,4,5,43,44] including exercise [45], psychological stress [46], surgery [47], sleep deprivation [48], and cold pressor-induced hypertension [49]. Previous work in our laboratory has demonstrated that 45 minutes of painful electrical stimulation in healthy controls was sufficient to produce significant elevations in plasma catecholamines and concomitant increases in the number of CD8 cells expressing CD11a and the density of the integrin molecules on the cells [15].

Based upon our previous study of the effects of painful stress in a human model, and because of the ubiquity and importance of pain as a negative stimulus, we decided to expand our investigation. Pain experiences vary by multiple dimensions, including length, duration, and intensity. Having explored the effects of a constant stimulus over 45 minutes, we decided to focus on evaluating immediate responses to a single, acute stressor, experienced commonly by the victims of sudden traumatic events.

Importantly, there is evidence that an acute time course is consistent with responses in immune variables. Investigators found 4 minutes of cold water limb immersion was sufficient time to produce elevated plasma levels of catecholamines and soluble cellular adhesion molecules over 4 hours, returning to baseline after 15 hours [50]. Other investigations have found stressors produced rapidly elevated expression of leukocyte celluar adhesion molecules measured in minutes, with a brief time course of elevation and immediate return to baseline values [3, 4, 5, 14, 15, 44]. IL-6 was elevated following: 30 minutes of exercise stress and remained elevated when measured 2 hours post-stressor [51]; 45 minutes of epinephrine infusion, remaining elevated when measured 1 hour post-infusion [52]; and 60 minutes of restraint stress, returning to baseline when measured 6 hours post-stressor [38].

Nguyen et al, [53] found hypothalamic levels of IL-1β elevated immediately after painful stress in a rodent model and at 2 hours post-stressor, with a return to baseline levels 24 hours post-stressor. Immediately following CPT (within 5 minutes), Eller (1998)[54] found elevations in catecholamines, heart rate, cytotoxic lymphocytes, natural killer cell numbers, and natural killer cell cytotoxicity in adults with and without HIV disease, with return to baseline values by one hour post-stressor. Multiple investigators have found elevated central nervous system and peripheral circulating levels of IL-1 less than 15 minutes after the stressor in rodent models of inescapable tail shock, with site-specific post-stressor elevations measured in hours [39; 53; 55]. Investigators speculated that neural pain signals affected pre-formed stores of pro-IL-1, resulting in rapid transformation and release of IL-1 molecules. Furthermore, investigators found that a single episode of inescapable tail shock was sufficient to produce an acute phase response in the animals, providing evidence of a systemic inflammatory response to this painful stressor, and producing rapid increases in core body temperature persisting for > 24 hours [56].

Thus in the current study, the expression of the integrin CD11a on CD8+ leukocytes was elevated after CPT with a marginal difference between conditions (p < .06). The CPT model produced VAS pain scores in the moderate to severe range, though mean scores were in the lower one-third of the SFMPQ range; mean stress scores were only at one-half of the VAS range (see Table 2). As a consequence of the painful stimulus, the autonomic responses (HR and MAP) were significantly elevated following CPT. This suggests a notable sympathetic nervous system activation and catecholamine release [36]. Thus, it is reasonable to speculate that the changes in inflammatory activity may be associated with sympathetic activation in this experiment.

In the current investigation, IL-1RA was observed to increase marginally following CPT. Though the IL-6 increase following CPT was not significant and admittedly small, the positive pain-associated change was different from that seen in the control state (p < .02). Numerous pre-clinical investigations have demonstrated that painful stress in the form of tail or paw electrical shock can produce elevation of proinflammatory cytokines (IL-1 and IL-6) in the plasma and central nervous system of animals [39,42, 53, 55, 57,58,].

However, stress states in humans have been demonstrated to exert complex effects upon the activity of proinflammatory cytokines. Catecholamine-generating exercise and epinephrine infusion have been found to increase plasma levels of IL-6 in healthy controls [52], while reducing stimulated ex vivo mononuclear cell TNF-α and IL-1β production [14,51]. Other investigators have identified a human subpopulation in which epinephrine output correlates negatively with proinflammatory cytokine production, and concluded that baseline epinephrine production pre-conditions cytokine responsiveness [59].

Thus in the current investigation, three immune variables demonstrated changes following CPT pain. Though not statistically significant, the larger magnitude of the change scores pre- and post-CPT between conditions (see the Figure) appear to support the possibility of a positive inflammatory response to this experimental painful stimulus, possibly related to the stress-induced sympathetic adrenergic response.

The current study had a number of limitations. The findings in the current study may have been influenced by the moderate nature of the experimental pain stimulus. The small sample size is a significant limitation, due to the sizable individual variations in immune responses (see Table 3). The timing of the blood draws may have influenced the ability to detect changes in variables with longer response times. The complex interactions of the neuro-inflammatory system in humans may also influenced the study; e.g., the limited number of variables examined makes it impossible to investigate feedback loops among pleiotropic mediator molecules such as IL-6, which can also exert anti-inflammatory effects via inhibition of tumor necrosis-α (TNF-α) and IL-1β.

Clearly, definitive data defining the immune inflammatory changes following an acute painful stimulus awaits further, larger investigations. The small changes in this study indicate caution in clinical interpretation. However, if the trend in these findings represents true positive alterations in the immune inflammatory balance of these subjects, these findings may have implications for the clinical care of patients with inflammatory syndromes, in that associated pain may actually worsen the prognosis by initiating a positive feedback system. These findings lend support to early and aggressive interventions to effectively prevent and treat pain, which may improve the course of immune inflammatory disease states. Further investigations will no doubt help to determine the implications for nociceptive pain on inflammatory immune responses.

Acknowledgment

This study was funded by a Post-Doctoral Fellowship Grant from the American Association of Nurse Anesthetists Research Foundation; NINR Grant#1 RO3 NR009106-01A1; Norman Cousins Center for Psychoneuroimmunology; UCLA General Clinical Research Center NIH/NCRR grant No. M01-RR00865; UCLA Claude D. Pepper Older Americans Center, NIA 5P AG028748

References

1. Dahl JB, Kehlet H. Postoperative pain and its management. In: McMahon SB, Koltzenburg M, editors. Wall and Melzack’s Textbook of pain. Philadelphia: Elsevier Churchill Livingstone; 2006. pp. 635–651.
2. Meyer RA, Ringkamp M, Campbell JN, Srinivasa NR. Peripheral mechanisms of cutaneous nociception. In: McMahon SB, Koltzenburg M, editors. Wall and Melzack’s Textbook of pain. Philadelphia: Elsevier Churchill Livingstone; 2006. pp. 3–34.
3. Mills PJ, Farag N, Perez C, Dimsdale J. Peripheral blood mononuclear cell CD62L and Cd11a expression and soluble interstitial cell adhesion molecule-1 levels following infused isoproterenol in hypertension. Journal of Hypertension. 2002;20:311–316. [PubMed]
4. Mills PJ, Goebel M, Rehman J, Irwin MR, Maisel A. Leukocyte adhesion molecule expression and T cell naïve/memory status following isoproterenol infusion. J Neuroimmunology. 2000;102:137–144. [PubMed]
5. Mills PJ, Maisel AS, Ziegler MG, Dimsdale JE, Carter S, Kennedy B, et al. Peripheral blood mononuclear cell-endothelial adhesion in human hypertension following exercise. Journal of Hypertension. 2000;18:1801–1806. [PubMed]
6. Bierhaus A, Wolf J, Andrassy M, Rohleder N, Humpbert P, Petrov D, Ferstl R. A mechanism converting psychosocial stress into mononuclear cell activation. PNAS. 2003;100(4):1920–1925. [PubMed]
7. Madrigal JL, Hurtado O, Moro MA, Lizasoain I, Lorenzo P, Castrillo A, et al. The increase in TNF-α levels is implicated in NF-κB activation and inducible nitric oxide synthase expression inn brain cortex after immobilization stress. Neuropsychopharmacology. 2000;26(2):155–163. [PubMed]
8. Munhoz C, Garcia-Bueno B, Madrigal J, Lepsch L, Scavone C, Leza J. Stress-induced neuroinflammation: mechanisms and new pharmacological targets. Brazilian Journal of Medical and Biological Research. 2008;41:1037–1046. [PubMed]
9. Pace TW, Mletzko TC, Alagbe O, Musselman DL, et al. Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Amer J Psych. 2006;163:1630–1633. [PubMed]
10. Wolf J, Rohleder N, Bierhaus A, Nawroth P, Kirschbaum C. Determinants of the NF-kappaB response to acute psychosocial stress in humans. Brain Behav Immun. 2009;23(6):742–749. [PubMed]
11. Adler K, Mills P, Dimsdale J, Ziegler J, Patterson T, Sloan R, et al. Temporal stability of acute stress-induced changes in leukocyte subsets and cellular adhesion molecules in older adults. Brain Behav Immun. 2002;16(3):262–274. [PubMed]
12. Curry JM, Hanke ML, Piper MG, Bailey MT, Bringardner BD, Sheridan JF, Marsh CB. Social disruption induces lung inflammation. Brain Behav Immun. 2010;24(3):394–402. [PMC free article] [PubMed]
13. Greeson JM, Lewis JG, Achanzar K, Zimmerman E, Young KH, Suarez EC. Stress-induced changes in the expression of monocytic beta2-integrins:the impact of arousal of negative affect and adrenergic responses to the Anger Recall Interview. Brain Behav Immun. 2009;23(2):251–256. [PMC free article] [PubMed]
14. Goebel M, Mills P. Acute psychological stress and exercise and changes in peripheral leukocyte adhesion molecule expression and stability. Psychosomatic Medicine. 2000;62:664–670. [PubMed]
15. Griffis CA, Irwin MR, Martinez-Maza O, Doering L, Nyamathi A, Kaufman R, et al. Pain-related activation of leukocyte cellular adhesion molecules: preliminary findings. Neuroimmunomodulation. 2007;14:224–228. [PubMed]
16. Simone DA, Kajander KC. Responses of cutaneous A-fiber nociceptors to noxious cold. J Neurophysiol. 1997;77(4):2049–2060. [PubMed]
17. Tassorelli C, Miciell G, Osipova V, Rossi R, Nappi G. Pupillary and cardiovascular responses to the cold-pressor test. J Auton Nerv Syst. 1995;55(1–2):45–49. [PubMed]
18. Blitz B, Dinnerstein A. Effects of different types of instruction on pain parameters. J.Abnorm.Psychol. 1968;73(3):276–280. [PubMed]
19. Chery-Croze S. Relationship between noxious cold stimuli and the magnitude of pain sensation in man. Pain. 1983;15(3):265–269. [PubMed]
20. Garcia de Jalon PD, Harrison FJ, Johnson KI, Kozma C, Schnelle K. A modified cold stimulation technique for the evaluation of analgesic activity in human volunteers. Pain. 1985;22(2):183–189. [PubMed]
21. Wolff BB, Kantor TG, Cohen P. Laboratory pain induction methods for human analgesic assays. In: Bonica JJ, Albe-Fessard D, editors. Advances in pain research and therapeutics. vol 1. New York: Raven Press; 1976. pp. 363–367.
22. Chen AC, Dworkin SF, Haug J, Gehrig J. Human pain responsivity in a tonic pain model: psychological determinants. Pain. 1989;37(2):143–160. [PubMed]
23. Eckhardt K, Li S, Ammon S, Schanzle G, Mikus G, Eichelbaum M. Same incidence of adverse drug events after codeine administration irrespective of the genetically determined differences in morphine formulation. Pain. 1998;76:27–33. [PubMed]
24. Georgoudis G, Oldham J, Watson P. Reliability and sensitivity measures of the Greek version of the short form of the McGill Pain Questionnnaire. European Journal of Pain. 1985;5(2):109–118. [PubMed]
25. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain. 1975;1:277–299. [PubMed]
26. Melzack R, Katz J. Pain measurement in persons in pain. In: Wall P, Melzack R, editors. Textbook of pain. New York: Churchill Livingstone; 1999. pp. 409–426.
27. Melzack R, Torgerson W. On the language of pain. Anesthesiology. 1971;34(1):50–59. [PubMed]
28. Turk DC, Rudy TE, Salovey P. The McGill Pain Questionnaire reconsidered: confirming the factor structure and examining appropriate uses. Pain. 1985;21(4):385–397. [PubMed]
29. Chapman C. Pain measurement: an overview. Pain. 1985;22(1):1–31. [PubMed]
30. Melzack R. The McGill Pain Questionnaire from description to measurement. Anesthesiology. 2005;103:199–202. [PubMed]
31. Wilkie D, Savedra M, Holzemer W, Tesler M, Paul S. Use of the McGill Pain Questionnaire to measure pain: a meta-analysis. Nursing Research. 1990;39(1):36–41. [PubMed]
32. Melzack R. The short-form McGill Pain Questionnaire. Pain. 1987;30(2):191–197. [PubMed]
33. Gift A. Visual analogue scales: measurement of subjective phenomena. Nursing Research. 1989;38(5):286–288. [PubMed]
34. Jannsen S, Spinhoven P, Arntz A. The effect of failing to control pain: an experimental investigation. Pain. 2004;107:227–233. [PubMed]
35. Wells N, Murphy B, Wujcik D, Johnson R. Pain-related distress and interference with daily life of ambulatory patients with cancer pain. Oncology Nursing Forum. 2003;30(6):977–986. [PubMed]
36. Guyton A, Hall JE. Textbook of Medical Physiology. 11th ed. Philadelphia: Elsevier Saunders; 2006.
37. Fabbri M, Bianchi E, Fumagalli L, Pardi R. Regulation of lymphocyte traffic by adhesion molecules. Inflammation Research. 1999;48:239–246l. [PubMed]
38. Nukina H, Sudo N, Aiba Y, Oyama N, Koga Y, Kubo C. Restraint stress elevates the plasma interleukin-6 levels in germ-free mice. Journal of Neuroimmunology. 2001;115:46–52. [PubMed]
39. Deak T, Bordner K, McElderry N, Barnum C, Blandino P, Deak M, Tammariello S. Stress-induced increases in hypothalamic IL-1: a systematic analysis of multiple stressor paradigms. Brain Research Bulletin. 2005;64:541–556. [PubMed]
40. Arend W, Malyak M, Guthridge C, Gabay C. Interleukin-1 receptor antagonist: role in biology. Ann Rev Immunol. 1998;16:27–55. [PubMed]
41. Zhang T, Chen Y, Liu H, Zhou Z, Zhai Y, Yang J. Chronic unpredictable stress accelerates atherosclerosis through promoting inflammation in apolipoprotein E knockout mice. Thrombosis Research. 2010;126:386–392. [PubMed]
42. Zhou A, Kusnecov A, Shurin M, DePaoli M, Rabin B. Exposure to physical and psychological stressors elevates plasma interleukin 6: Relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology. 1993;133:2523–2530. [PubMed]
43. Kuhlwein E, Irwin M, Ziegler M, Woods V, Kennedy B, Mills P. Propranolol affects stress-induced leukocytosis and cellular adhesion molecule expression. Eur.J. Appl Physiolo. 2001;86:135–141. [PubMed]
44. Redwine L, Snow S, Mills P, Irwin M. Acute psychological stress: effects on chemotaxis and cellular adhesion molecule expression. Psychosomatic Medicine. 2003;65:598–603. [PubMed]
45. Rehman J, Mills P, Carter S, Chou J, Thomas J, Maisel A. Dynamic exercise leads to an increase in circulating ICAM-1: Further evidence for adrenergic modulation of cell adhesion. Brain Behav and Immunity. 1997;11:343–351. [PubMed]
46. Shamini J, Mills P, Von Kanel R, Hong S, Dimsdale J. Effects of perceived stress and uplifts on inflammation and coagulability. Psychophysiology. 2007;44(1):154–160. [PubMed]
47. Lin M, Yeh S, Wu M, Lin J, Lee P, Liaw K, et al. Impact of surgery on local and systemic responses of cytokines and adhesion molecules. Hepatogastroenterology. 2009;56(94–95):1341–1345. [PubMed]
48. Ranjbaran Z, Keefer L, Stepanski E, Farhadi A, Keshavarzian A. The relevance of sleep abnormalities to chronic inflammatory conditions. Inflamm Res. 2007;56(2):51–57. [PubMed]
50. Buemi M, Allegra A, Aloisi C, Corica F, Alonci A, Ruello A, et al. Cold pressor test raises serum concentrations of ICAM-1, VCAM-1, and E selectin in normotensive and hypertensive patients. Hypertension. 1997;30:845–847. [PubMed]
51. Steensberg A, Toft A, Schjerling P, Halkjer-Kristensen J, Pedersen B. Plasma interleukin-6 during strenuous exercise: role of epinephrine. American Journal of Physiology and Cell Physiology. 2001;281:C1001–C1004. [PubMed]
52. Sondergaard S, Ostrowski K, Ullum H, Pedersen B. Changes in plasma levels of IL-6 and IL-1ra in response to adrenaline. European Journal of Applied Physiology. 2000;83:95–98. [PubMed]
53. Nguyen K, Deak T, Will M, Hansen M, Hunsaker B, Fleshner M, et al. Timecourse and corticosterone sensitivity of the brain, pituitary, and serum interleukin-1 beta protein response to acute stress. Brain Research. 2000;859:193–201. [PubMed]
54. Eller L. Testing a model: Effects of pain on immunity in HIV+ and HIV− participants. Scholarly Inquiry for Nursing Practice. 1998;12(3):191–214. [PubMed]
55. O’Connor K, Johnson J, Hansen M, Wieseler-Frank J, Maksimova E, Watkins LR, et al. Peripheral and central proinflammatory cytokine response to a severe acute stressor. Brain Research. 2003;991:123–132. [PubMed]
56. Deak T, Meriwether J, Fleshner M, Spencer R, Abouhamze A, Moldawer L, Grahn R, Watkins L, Maier S. Evidence that brief stress may induce the acute phase response in rats. Amer. J. Physiology. 1997;273:1998–2004. [PubMed]
57. Johnson J, Campisi J, Sharkey C, Kennedy S, Nickerson M, Greenwood B, et al. Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience. 2005;135(4):1295–1307. [PubMed]
58. Johnson J, O’Connor K, Watkins L, Watkins S. The role of IL-1β in stress-induced sensitization of proinflammatory cytokine and corticosterone responses. Neuroscience. 2004;127:569–577. [PubMed]
59. Elenkov I, Kvetnansky R, Hashiramoto A, Bakalov V, Link A, Zachman K, et al. Low- versus High-baseline epinephrine output shapes opposite innate cytokine profiles: presence of Lewis- and Fischer-like nuerohormonal immune phenotypes in humans? Journal of Immunology. 2008;18:1737–1745. [PubMed]